ArticleEcotoxicology (London, England)2026
Neonicotinoid insecticide thiamethoxam compromises early larval development of the Amazonian tetra fish Astyanax bimaculatus (Linnaeus, 1758).
Article in Ecotoxicology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thiamethoxam (TMX) is a widely used neonicotinoid insecticide with high water solubility, which increases the likelihood of contamination in freshwater systems. Here, we assessed lethal and sublethal effects of TMX on the early life stages of the Neotropical Amazonian fish Astyanax bimaculatus. Two assays were performed: (i) embryonic exposure under static conditions (0, 0.05, 0.5, 5, and 50 mg/L; 200 embryos per treatment) and (ii) 96-h acute toxicity test on 1-day post-hatch larvae under semi-static conditions (0, 5, 25, and 50 mg/L; three aquaria of 100 larvae per treatment). During embryonic exposure, a visible coating over the chorion was observed at 5 and 50 mg/L, coinciding with both reduced normal hatching and increased larval deformities. The proportion of normally hatched larvae decreased from 97.5% in the control to 60.0% at 50 mg/L, while deformities increased to 15.5%, and unhatched embryos reached 24.5%. Post-hatch morphometry showed significant reductions in total length and yolk sac dimensions at concentrations ≥ 0.5 mg/L. In the larval assay, mortality increased in a dose-dependent manner, reaching mean values of 22.7%, 32.3%, and 64.0% at 5, 25, and 50 mg/L, respectively; the 96 h LC50 was 35.63 mg/L (95% CI: 27.83-43.44 mg/L). Overall, TMX impaired the survival and early development of A. bimaculatus, supporting the inclusion of early-life stage endpoints in the monitoring and risk assessment of Amazonian freshwater environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.